MyAverix Finance
US · Healthcare
Rafarma Pharmaceuticals Inc (RAFA)
Drug Manufacturers - Specialty & Generic
Rafarma Pharmaceuticals Inc (RAFA) is listed on US in the Healthcare sector. Industry: Drug Manufacturers - Specialty & Generic. As of 2026-05-23, reported P/E ratio is 18.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for RAFA
Rafarma Pharmaceuticals Inc (RAFA) — FAQ
What is RAFA's P/E ratio?
The price-to-earnings (P/E) ratio for Rafarma Pharmaceuticals Inc (RAFA) is 18.00 (data as of 2026-05-23).
Does Rafarma Pharmaceuticals Inc pay a dividend?
Dividend yield is not available in the current snapshot for Rafarma Pharmaceuticals Inc (RAFA). Check the MyAverix Finance app for the latest dividend data.
What sector is Rafarma Pharmaceuticals Inc in?
Rafarma Pharmaceuticals Inc (RAFA) is classified in the Healthcare sector (Drug Manufacturers - Specialty & Generic industry).
What exchange is RAFA listed on?
RAFA is listed on US.
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.